» Articles » PMID: 16098465

Early Inactivation of P53 Tumor Suppressor Gene Cooperating with NF1 Loss Induces Malignant Astrocytoma

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2005 Aug 16
PMID 16098465
Citations 264
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant astrocytoma, the most prevalent primary brain tumor, is resistant to all known therapies and frequently harbors mutations that inactivate p53 and activate Ras signaling. We have generated mouse strains that lack p53 and harbor a conditional allele of the NF1 tumor suppressor that negatively regulates Ras signaling. The mice develop malignant astrocytomas with complete penetrance. The majority of tumors display characteristics of glioblastoma multiforme with concomitant alteration of signaling pathways previously described in the human counterparts of this neoplasm. We find that the sequence of tumor suppressor inactivation influences tumorigenicity and that earliest evidence of tumor formation localizes to regions of the brain that contain a multipotent stem cell population capable of in vivo differentiation into neurons and glia.

Citing Articles

The role of lncRNAs in the interplay of signaling pathways and epigenetic mechanisms in glioma.

Bora Yildiz C, Du J, Mohan K, Zimmer-Bensch G, Abdolahi S Epigenomics. 2025; 17(2):125-140.

PMID: 39829063 PMC: 11792803. DOI: 10.1080/17501911.2024.2442297.


Endothelial-secreted Endocan activates PDGFRA and regulates vascularity and spatial phenotype in glioblastoma.

Bastola S, Pavlyukov M, Sharma N, Ghochani Y, Nakano M, Muthukrishnan S Nat Commun. 2025; 16(1):471.

PMID: 39773984 PMC: 11707362. DOI: 10.1038/s41467-024-55487-1.


Bridging the gap between tumor and disease: Innovating cancer and glioma models.

Cirigliano S, Fine H J Exp Med. 2024; 222(1).

PMID: 39626263 PMC: 11614461. DOI: 10.1084/jem.20220808.


Human stem cell models to unravel brain cancer.

Dave B, Tailor J BMC Cancer. 2024; 24(1):1465.

PMID: 39609728 PMC: 11603633. DOI: 10.1186/s12885-024-13187-5.


Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence.

Xie X, Ganbold M, Li J, Lien M, Chipman M, Wang T Neuron. 2024; 112(24):4017-4032.e6.

PMID: 39510072 PMC: 11659040. DOI: 10.1016/j.neuron.2024.10.012.


References
1.
Guha A, Dashner K, Black P, Wagner J, Stiles C . Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer. 1995; 60(2):168-73. DOI: 10.1002/ijc.2910600206. View

2.
Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, Westermark B . Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Res. 1996; 56(1):164-71. View

3.
Gutmann D, Giordano M, Mahadeo D, Lau N, Silbergeld D, Guha A . Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras. Oncogene. 1996; 12(10):2121-7. View

4.
Kinzler K, Vogelstein B . Lessons from hereditary colorectal cancer. Cell. 1996; 87(2):159-70. DOI: 10.1016/s0092-8674(00)81333-1. View

5.
Ridet J, Malhotra S, Privat A, Gage F . Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1998; 20(12):570-7. DOI: 10.1016/s0166-2236(97)01139-9. View